Lusvertikimab (Anti-IL-7Ra / CD127)
Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2669 |
Sku # | A2669-1mg |
Pricing | 1mg, $370.00 |